The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

BACKGROUND: Aztreonam lysine for inhalation (AZLI) is an inhaled antibiotic used to treat chronic Pseudomonas aeruginosa infection in CF. AZLI improves lung function and quality of life, and reduces exacerbations-improvements attributed to its antipseudomonal activity. Given the extremely high aztre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Microbiome
Autors principals: Heirali, Alya A., Workentine, Matthew L., Acosta, Nicole, Poonja, Ali, Storey, Douglas G., Somayaji, Ranjani, Rabin, Harvey R., Whelan, Fiona J., Surette, Michael G., Parkins, Michael D.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5420135/
https://ncbi.nlm.nih.gov/pubmed/28476135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40168-017-0265-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars